Brain Health in 2030: Navigating Neuroplasticity & the Digital Health Market

By SharpBrains | January 23, 2024 |

Brain Health in 2030: Nav­i­gat­ing Neu­ro­plas­tic­i­ty & the Dig­i­tal Health Mar­ket from Sharp­Brains Keynote deliv­ered by Álvaro Fer­nán­dez, CEO of Sharp­Brains, dur­ing cor­po­rate retreat. Key mes­sage: Our very human brains and minds are the most sophis­ti­cat­ed tech­nol­o­gy at our dis­pos­al, so we should invest more time learn­ing about how they work and har­ness­ing neu­ro­­plas­tic­i­­ty-based methods…

Read More

On the 7 Habits of Highly Stress-Resilient Minds, cognitive screenings, anti-amyloid drugs, and more

By SharpBrains | April 27, 2023

Wel­come to a new edi­tion of Sharp­Brains e‑newsletter, this time cov­er­ing the lat­est devel­op­ments in stress research, med­i­ta­tion, vir­tu­al real­i­ty, anti-amy­loid drugs, cog­ni­tive screen­ings, and more. #1. The 7 Habits of High­ly Stress-Resilient Minds “Any­thing worth doing will have aspects of stress woven through: chal­lenge, dis­com­fort, risk. We can’t change that. But what we can change is…

Read More

Digital therapeutics pioneer Akili Interactive Labs goes public, raising $150M+; trades down 49% first day

By SharpBrains | August 23, 2022

Akili Inter­ac­tive is the lat­est com­pa­ny to go pub­lic via SPAC deal (Boston Busi­ness Jour­nal): Boston’s Akili Inter­ac­tive Labs Inc. is the lat­est Mass­a­chu­setts-based com­pa­ny to go pub­lic after com­plet­ing a reverse merg­er — in a year of mar­ket tur­moil that saw few local firms pass­ing the thresh­old between pri­vate and pub­lic sta­tus. Shares of…

Read More

Next: Analyzing typing speed, speech and sleep patterns to identify cognitive decline, dementia, Parkinson’s, and more

By SharpBrains | November 19, 2020

AI May Help Iden­ti­fy Patients With Ear­­ly-Stage Demen­tia (The Wall Street Jour­nal): Researchers are study­ing whether arti­­fi­­cial-intel­li­­gence tools that ana­lyze things like typ­ing speed, sleep pat­terns and speech can be used to help clin­i­cians bet­ter iden­ti­fy patients with ear­­ly-stage dementia.

Read More

Five Essential Guidelines to Improve Brain Health for All

By SharpBrains | May 2, 2019

Since 2010, the Sharp­Brains Vir­tu­al Sum­mit has been bring­ing togeth­er neu­ro­sci­en­tists, entre­pre­neurs, and prac­ti­tion­ers with a mis­sion to improve men­tal health­care, brain per­for­mance and gen­er­al well-being. As we get ready to host our next col­lec­tive brain­storm­ing next week, let us share some key themes from our last Sum­mit, since they helped shape the Agen­da for…

Read More

Sanofi Ventures leads $17M investment in Click Therapeutics, finalist @ 2017 Brainnovations Pitch Contest

By SharpBrains | July 25, 2018

Sanofi Backs Click Ther­a­peu­tics as Dig­i­tal Med­i­cines Gain Momen­tum (Xcon­o­my): “Drug mak­ers are mak­ing more bets on the nascent field of dig­i­tal med­i­cine. The lat­est exam­ple: Click Ther­a­peu­tics announced Mon­day that it grabbed a $17 mil­lion invest­ment led by Sanofi Ven­tures, the Cam­bridge, MA-based ven­ture cap­i­tal arm of the French phar­ma­ceu­ti­cal giant.

Read More